# Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function

> **NCT01320722** · PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 242 (actual)

## Conditions studied

- Renal Function
- Endothelial Function
- Blood Pressure
- Overweight
- Obesity

## Interventions

- **DRUG:** Vitamin D ergocalciferol
- **DRUG:** Probenecid
- **DRUG:** Allopurinol
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01320722
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2017-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320722, "Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01320722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*